Persons with dispensed medicines; origin
| Sex | Age | Origin | Medicine group (ATC) | Periods | Persons with medicines, relative (%) |
|---|---|---|---|---|---|
| Total male and female | Total age | Total | C01D Vasodilators used in card. diseases | 2024* | 1.38 |
| Total male and female | Total age | Total | M05 Drugs for treatment of bone diseases | 2024* | 1.25 |
| Total male and female | Total age | Total | R03 Drugs for obstruct. airway diseases | 2024* | 8.44 |
| Total male and female | Total age | Origin: born in the Netherlands | C01D Vasodilators used in card. diseases | 2024* | 1.43 |
| Total male and female | Total age | Origin: born in the Netherlands | M05 Drugs for treatment of bone diseases | 2024* | 1.36 |
| Total male and female | Total age | Origin: born in the Netherlands | R03 Drugs for obstruct. airway diseases | 2024* | 8.94 |
| Total male and female | Total age | Origin: born in NL, parents in NL | C01D Vasodilators used in card. diseases | 2024* | 1.55 |
| Total male and female | Total age | Origin: born in NL, parents in NL | M05 Drugs for treatment of bone diseases | 2024* | 1.49 |
| Total male and female | Total age | Origin: born in NL, parents in NL | R03 Drugs for obstruct. airway diseases | 2024* | 9.08 |
| Total male and female | Total age | Origin: born in NL, parent(s) abroad | C01D Vasodilators used in card. diseases | 2024* | 0.72 |
| Total male and female | Total age | Origin: born in NL, parent(s) abroad | M05 Drugs for treatment of bone diseases | 2024* | 0.58 |
| Total male and female | Total age | Origin: born in NL, parent(s) abroad | R03 Drugs for obstruct. airway diseases | 2024* | 8.09 |
| Total male and female | Total age | Origin: born in NL, 1 parent born in NL | C01D Vasodilators used in card. diseases | 2024* | 1.08 |
| Total male and female | Total age | Origin: born in NL, 1 parent born in NL | M05 Drugs for treatment of bone diseases | 2024* | 0.91 |
| Total male and female | Total age | Origin: born in NL, 1 parent born in NL | R03 Drugs for obstruct. airway diseases | 2024* | 8.73 |
| Total male and female | Total age | Origin: born in NL,2 parents born abroad | C01D Vasodilators used in card. diseases | 2024* | 0.30 |
| Total male and female | Total age | Origin: born in NL,2 parents born abroad | M05 Drugs for treatment of bone diseases | 2024* | 0.19 |
| Total male and female | Total age | Origin: born in NL,2 parents born abroad | R03 Drugs for obstruct. airway diseases | 2024* | 7.34 |
| Total male and female | Total age | Origin: born abroad | C01D Vasodilators used in card. diseases | 2024* | 1.16 |
| Total male and female | Total age | Origin: born abroad | M05 Drugs for treatment of bone diseases | 2024* | 0.70 |
| Total male and female | Total age | Origin: born abroad | R03 Drugs for obstruct. airway diseases | 2024* | 6.03 |
| Total male and female | Total age | Origin country: The Netherlands | C01D Vasodilators used in card. diseases | 2024* | 1.55 |
| Total male and female | Total age | Origin country: The Netherlands | M05 Drugs for treatment of bone diseases | 2024* | 1.49 |
| Total male and female | Total age | Origin country: The Netherlands | R03 Drugs for obstruct. airway diseases | 2024* | 9.08 |
| Total male and female | Total age | Origin country: abroad | C01D Vasodilators used in card. diseases | 2024* | 0.98 |
| Total male and female | Total age | Origin country: abroad | M05 Drugs for treatment of bone diseases | 2024* | 0.65 |
| Total male and female | Total age | Origin country: abroad | R03 Drugs for obstruct. airway diseases | 2024* | 6.86 |
| Total male and female | Total age | Origin country: Europe (excl. NL) | C01D Vasodilators used in card. diseases | 2024* | 0.96 |
| Total male and female | Total age | Origin country: Europe (excl. NL) | M05 Drugs for treatment of bone diseases | 2024* | 0.79 |
| Total male and female | Total age | Origin country: Europe (excl. NL) | R03 Drugs for obstruct. airway diseases | 2024* | 5.73 |
| Total male and female | Total age | Origin country: outside Europe | C01D Vasodilators used in card. diseases | 2024* | 0.99 |
| Total male and female | Total age | Origin country: outside Europe | M05 Drugs for treatment of bone diseases | 2024* | 0.58 |
| Total male and female | Total age | Origin country: outside Europe | R03 Drugs for obstruct. airway diseases | 2024* | 7.45 |
| Total male and female | Total age | Origin country: Morocco | C01D Vasodilators used in card. diseases | 2024* | 0.74 |
| Total male and female | Total age | Origin country: Morocco | M05 Drugs for treatment of bone diseases | 2024* | 0.48 |
| Total male and female | Total age | Origin country: Morocco | R03 Drugs for obstruct. airway diseases | 2024* | 8.60 |
| Total male and female | Total age | Origin country: Turkey | C01D Vasodilators used in card. diseases | 2024* | 1.44 |
| Total male and female | Total age | Origin country: Turkey | M05 Drugs for treatment of bone diseases | 2024* | 0.61 |
| Total male and female | Total age | Origin country: Turkey | R03 Drugs for obstruct. airway diseases | 2024* | 8.15 |
| Total male and female | Total age | Origin country: Suriname | C01D Vasodilators used in card. diseases | 2024* | 1.88 |
| Total male and female | Total age | Origin country: Suriname | M05 Drugs for treatment of bone diseases | 2024* | 0.68 |
| Total male and female | Total age | Origin country: Suriname | R03 Drugs for obstruct. airway diseases | 2024* | 10.38 |
| Total male and female | Total age | Origin country: Dutch Caribbean | C01D Vasodilators used in card. diseases | 2024* | 0.66 |
| Total male and female | Total age | Origin country: Dutch Caribbean | M05 Drugs for treatment of bone diseases | 2024* | 0.40 |
| Total male and female | Total age | Origin country: Dutch Caribbean | R03 Drugs for obstruct. airway diseases | 2024* | 8.08 |
| Total male and female | Total age | Origin country: Indonesia | C01D Vasodilators used in card. diseases | 2024* | 2.15 |
| Total male and female | Total age | Origin country: Indonesia | M05 Drugs for treatment of bone diseases | 2024* | 1.63 |
| Total male and female | Total age | Origin country: Indonesia | R03 Drugs for obstruct. airway diseases | 2024* | 11.16 |
| Total male and female | Total age | Origin country: Outside Europe (exc. 5.. | C01D Vasodilators used in card. diseases | 2024* | 0.52 |
| Total male and female | Total age | Origin country: Outside Europe (exc. 5.. | M05 Drugs for treatment of bone diseases | 2024* | 0.37 |
| Total male and female | Total age | Origin country: Outside Europe (exc. 5.. | R03 Drugs for obstruct. airway diseases | 2024* | 5.41 |
| Total male and female | 0 to 14 years | Total | C01D Vasodilators used in card. diseases | 2024* | 0.00 |
| Total male and female | 0 to 14 years | Total | M05 Drugs for treatment of bone diseases | 2024* | 0.00 |
| Total male and female | 0 to 14 years | Total | R03 Drugs for obstruct. airway diseases | 2024* | 6.27 |
| Total male and female | 0 to 14 years | Origin: born in the Netherlands | C01D Vasodilators used in card. diseases | 2024* | 0.00 |
| Total male and female | 0 to 14 years | Origin: born in the Netherlands | M05 Drugs for treatment of bone diseases | 2024* | 0.00 |
| Total male and female | 0 to 14 years | Origin: born in the Netherlands | R03 Drugs for obstruct. airway diseases | 2024* | 6.51 |
| Total male and female | 0 to 14 years | Origin: born in NL, parents in NL | C01D Vasodilators used in card. diseases | 2024* | 0.00 |
| Total male and female | 0 to 14 years | Origin: born in NL, parents in NL | M05 Drugs for treatment of bone diseases | 2024* | 0.00 |
| Total male and female | 0 to 14 years | Origin: born in NL, parents in NL | R03 Drugs for obstruct. airway diseases | 2024* | 6.43 |
| Total male and female | 0 to 14 years | Origin: born in NL, parent(s) abroad | C01D Vasodilators used in card. diseases | 2024* | 0.00 |
| Total male and female | 0 to 14 years | Origin: born in NL, parent(s) abroad | M05 Drugs for treatment of bone diseases | 2024* | 0.00 |
| Total male and female | 0 to 14 years | Origin: born in NL, parent(s) abroad | R03 Drugs for obstruct. airway diseases | 2024* | 6.76 |
| Total male and female | 0 to 14 years | Origin: born in NL, 1 parent born in NL | C01D Vasodilators used in card. diseases | 2024* | 0.00 |
| Total male and female | 0 to 14 years | Origin: born in NL, 1 parent born in NL | M05 Drugs for treatment of bone diseases | 2024* | 0.00 |
| Total male and female | 0 to 14 years | Origin: born in NL, 1 parent born in NL | R03 Drugs for obstruct. airway diseases | 2024* | 6.99 |
| Total male and female | 0 to 14 years | Origin: born in NL,2 parents born abroad | C01D Vasodilators used in card. diseases | 2024* | 0.00 |
| Total male and female | 0 to 14 years | Origin: born in NL,2 parents born abroad | M05 Drugs for treatment of bone diseases | 2024* | 0.00 |
| Total male and female | 0 to 14 years | Origin: born in NL,2 parents born abroad | R03 Drugs for obstruct. airway diseases | 2024* | 6.52 |
| Total male and female | 0 to 14 years | Origin: born abroad | C01D Vasodilators used in card. diseases | 2024* | 0.00 |
| Total male and female | 0 to 14 years | Origin: born abroad | M05 Drugs for treatment of bone diseases | 2024* | 0.00 |
| Total male and female | 0 to 14 years | Origin: born abroad | R03 Drugs for obstruct. airway diseases | 2024* | 3.41 |
| Total male and female | 0 to 14 years | Origin country: The Netherlands | C01D Vasodilators used in card. diseases | 2024* | 0.00 |
| Total male and female | 0 to 14 years | Origin country: The Netherlands | M05 Drugs for treatment of bone diseases | 2024* | 0.00 |
| Total male and female | 0 to 14 years | Origin country: The Netherlands | R03 Drugs for obstruct. airway diseases | 2024* | 6.43 |
| Total male and female | 0 to 14 years | Origin country: abroad | C01D Vasodilators used in card. diseases | 2024* | 0.00 |
| Total male and female | 0 to 14 years | Origin country: abroad | M05 Drugs for treatment of bone diseases | 2024* | 0.00 |
| Total male and female | 0 to 14 years | Origin country: abroad | R03 Drugs for obstruct. airway diseases | 2024* | 5.91 |
| Total male and female | 0 to 14 years | Origin country: Europe (excl. NL) | C01D Vasodilators used in card. diseases | 2024* | 0.00 |
| Total male and female | 0 to 14 years | Origin country: Europe (excl. NL) | M05 Drugs for treatment of bone diseases | 2024* | 0.00 |
| Total male and female | 0 to 14 years | Origin country: Europe (excl. NL) | R03 Drugs for obstruct. airway diseases | 2024* | 5.05 |
| Total male and female | 0 to 14 years | Origin country: outside Europe | C01D Vasodilators used in card. diseases | 2024* | 0.00 |
| Total male and female | 0 to 14 years | Origin country: outside Europe | M05 Drugs for treatment of bone diseases | 2024* | 0.00 |
| Total male and female | 0 to 14 years | Origin country: outside Europe | R03 Drugs for obstruct. airway diseases | 2024* | 6.29 |
| Total male and female | 0 to 14 years | Origin country: Morocco | C01D Vasodilators used in card. diseases | 2024* | 0.00 |
| Total male and female | 0 to 14 years | Origin country: Morocco | M05 Drugs for treatment of bone diseases | 2024* | 0.00 |
| Total male and female | 0 to 14 years | Origin country: Morocco | R03 Drugs for obstruct. airway diseases | 2024* | 8.29 |
| Total male and female | 0 to 14 years | Origin country: Turkey | C01D Vasodilators used in card. diseases | 2024* | 0.00 |
| Total male and female | 0 to 14 years | Origin country: Turkey | M05 Drugs for treatment of bone diseases | 2024* | 0.00 |
| Total male and female | 0 to 14 years | Origin country: Turkey | R03 Drugs for obstruct. airway diseases | 2024* | 6.22 |
| Total male and female | 0 to 14 years | Origin country: Suriname | C01D Vasodilators used in card. diseases | 2024* | 0.00 |
| Total male and female | 0 to 14 years | Origin country: Suriname | M05 Drugs for treatment of bone diseases | 2024* | 0.01 |
| Total male and female | 0 to 14 years | Origin country: Suriname | R03 Drugs for obstruct. airway diseases | 2024* | 7.50 |
| Total male and female | 0 to 14 years | Origin country: Dutch Caribbean | C01D Vasodilators used in card. diseases | 2024* | 0.00 |
| Total male and female | 0 to 14 years | Origin country: Dutch Caribbean | M05 Drugs for treatment of bone diseases | 2024* | 0.00 |
| Total male and female | 0 to 14 years | Origin country: Dutch Caribbean | R03 Drugs for obstruct. airway diseases | 2024* | 8.32 |
| Total male and female | 0 to 14 years | Origin country: Indonesia | C01D Vasodilators used in card. diseases | 2024* | 0.00 |
| Total male and female | 0 to 14 years | Origin country: Indonesia | M05 Drugs for treatment of bone diseases | 2024* | 0.00 |
| Total male and female | 0 to 14 years | Origin country: Indonesia | R03 Drugs for obstruct. airway diseases | 2024* | 6.09 |
| Total male and female | 0 to 14 years | Origin country: Outside Europe (exc. 5.. | C01D Vasodilators used in card. diseases | 2024* | 0.00 |
| Source: CBS. | |||||
Table explanation
This table contains figures on the absolute number of persons to whom in the year concerned medicines were dispensed for which the costs are reimbursed under the statutory basic medical insurance. Also, the number of dispensed defined daily doses (DDDs) are presented. The figures are also expressed as a percentage of the total population in the category concerned. The population includes everybody registered in the Basic Registration of Persons (BRP) and living in the Netherlands at some point in the year concerned. Until 2010 the figures also included medicines dispensed to persons registered in the BRP, but no longer resident in the Netherlands.
Medicines provided to persons in hospitals and nursing homes are not included; medicines provided in residential homes for the elderly are included.
Data are broken down by medicine group, origin, age and sex.
Data available from 2020
Status of the figures:
Figures for 2024 are provisional, figures for previous years are final.
Changes as of December 18, 2025:
- Provisional figures for 2024 have been added, provisional figures of 2023 have been made definite.
- Figures for 2024 do not include DDD's as they are insufficiently reliable.
When will new figures be published?
New figures will be published in the last quarter of 2026.
Description topics
- Persons with medicines, relative
- Number of persons to whom medicines are dispensed in the year concerned that are reimbursed under the statutory basic medical insurance, expressed as a percentage of the total population of the category concerned registered in the Basic Registration of Persons (BRP) in that year.